60 Degrees Pharmaceuticals (SCTP) Proxy Filing summary

Executive summary

• The annual meeting will be held virtually on October 8, 2025, with voting available by phone or mail.

• Stockholders will vote on director elections, an equity plan amendment, a reverse stock split, auditor ratification, and potential adjournment.

• Proxy materials are distributed primarily online to reduce costs and environmental impact.

Voting matters and shareholder proposals

• Five directors are nominated for election to serve until the 2026 annual meeting.

• Proposal to amend the 2022 Equity Incentive Plan to increase authorized shares by 250,000.

• Proposal to amend the certificate of incorporation to effect a reverse stock split at a ratio of 1:3 to 1:10.

• Ratification of RBSM LLP as independent auditor for fiscal year 2025.

• Proposal to adjourn the meeting if more votes are needed for key proposals.

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Board consists of five directors, three of whom are independent under Nasdaq rules.

• Directors are elected annually; all current directors have served since July 2023.

• Board committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined charters.

• Board met five times in 2024, with full attendance by all directors.

• Stockholders can nominate directors by following advance notice procedures.